Moderna (MRNA) Tops Q4 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Coronavirus Stocks Surge on Increasingly Likely Pandemic
February 25, 2020 3:35 PM ESTCoronavirus stocks continue to soar as officials now see an increasingly likely pandemic.
Coronavirus stocks
Alpha Pro Tech Ltd. (NYSE: APT) +50%Moderna (NASDAQ: MRNA) +32%Lakeland Industries (NASDAQ: LAKE) +6%Co-Diagnostics (NASDAQ: CODX) +9.5%... MoreAvailability of Vaccines Could be Year to Year and Half - HHS
February 25, 2020 3:07 PM EST(Updated - February 25, 2020 3:18 PM EST)
(Updated - February 25, 2020 3:17 PM EST)
Community Spread of Coronavirus in Other Countries Outside China Very Concerning - HHS
Intimidate Risk in U.S. is Low, Must Continue to PrepareVaccine Development on Time, in Human Trial in Month and... MoreModerna (MRNA) Extends Gain, Up 30%
February 25, 2020 2:47 PM ESTModerna (NASDAQ: MRNA) Extends Gain, Up 30%
... MorePre-Open Stock Movers 2/25: (MNK) (LL) (MRNA) Higher (TUP) (PANW) (SHAK) Lower (more...)
February 25, 2020 9:21 AM ESTToday's Pre-Open Stock Movers
Mallinckrodt Plc (NYSE: MNK) 38.2% HIGHER; its specialty generic unit will file for bankruptcy protection as it agreed to settle opioid-related cases globally by paying $1.6 billion over eight years.
Moderna (MRNA) Reports First Shipment of mRNA Vaccine Against Novel Coronavirus (mRNA-1273) for Phase 1 Study
February 25, 2020 5:51 AM ESTModerna, Inc., (NASDAQ: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients today announced that it has released the first batch of mRNA-1273, the Companys vaccine against the novel coronavirus, for human use. Vials of mRNA-1273 have been shipped to the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH) to be used in the planned Phase 1 study in the U.S.
mRNA-1273 is an mRNA vaccine against the novel... More
Moderna (MRNA) calls active into disclosing shipment of mRNA vaccine for Phase 1 coronavirus study
February 25, 2020 5:15 AM ESTModerna (NASDAQ: MRNA) 30 option implied volatility is at 87; compared to its 52-week range of 51 to 99 into disclosing shipment of mRNA vaccine for Phase 1 coronavirus study. Call put ratio 6 calls to 1 put.
... MoreAfter-Hours Stock Movers 02/24: (MRNA) (MMSI) (NLS) Higher; (PANW) (EVER) (SHAK) Lower (more...)
February 24, 2020 5:57 PM ESTToday's After-Hours Stock Movers
Moderna (NASDAQ: MRNA) 14.7% HIGHER; shipped the first batch of its coronavirus vaccine to U.S. government researchers who will launch the first human tests, according to Dow Jones.
Palo Alto Networks (NYSE: PANW) 14.2% LOWER; reported Q2 EPS of $1.19, $0.07 better than the analyst estimate of $1.12. Revenue for the quarter came in at $816.7 million versus the consensus estimate of $843.26 million. Palo Alto Networks sees Q3 2020 EPS of $0.96-$0.98, versus the consensus of $1.25. Palo Alto Networks... More
Moderna (MRNA) Surges 15% After Shipping First Batch of Coronavirus Vaccine for Testing
February 24, 2020 5:34 PM ESTModerna (NASDAQ: MRNA) gains 15% after-hours following reports from Dow Jones the company shipped the first batch of its coronavirus vaccine to U.S. government researchers who will launch the first human tests.
... MoreModerna (MRNA) Delivers First Coronavirus Vaccine for Human Testing - DJ
February 24, 2020 4:46 PM ESTModerna (NASDAQ: MRNA) shipped the first batch of its coronavirus vaccine to U.S. government researchers who will launch the first human tests, according to Dow Jones.
